Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 21, 2019 - Issue 4
Submit an article Journal homepage
155
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate

Yegyu SungDepartment of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Republic of KoreaView further author information
,
Min Hee KimDivision of Endocrinology, Department of Internal Medicine, St. Paul’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaCorrespondence[email protected] [email protected]
View further author information
&
Eujin ChoDepartment of Dermatology, KAIST, Daejeon, Republic of Korea;Department of Dermatology, DeRAMA Dermatology Clinic, Seoul, KoreaView further author information
Pages 243-244 | Received 02 Apr 2018, Accepted 16 Sep 2018, Published online: 04 Oct 2018

References

  • Kontis TC. Contemporary review of injectable facial fillers. JAMA Facial Plast Surg. 2013;15:58–64. doi:10.1001/jamafacial.2013.337.
  • Cohen JL, Dayan SH, Brandt FS, Nelson DB, Axford-Gatley RA, Theisen MJ, Narins RS. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013;39:205–31. doi:10.1111/dsu.12036.
  • Gambacorti-Passerini C, Antolini L, Mahon FX, Guilhot F, Deininger M, Fava C, Nagler A, Della Casa CM, Morra E, Abruzzese E, et al. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. J Natl Cancer Inst. 2011;103:553–61. doi:10.1093/jnci/djr060.
  • Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295–316. doi:10.2147/CCID.S50546.
  • Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005;115:282–89.
  • Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588–95.
  • Tsao AS, Kantarjian H, Cortes J, O’Brien S, Talpaz M. Imatinib mesylate causes hypopigmentation in the skin. Cancer. 2003;98:2483–87. doi:10.1002/cncr.11812.
  • Amitay-Laish I, Stemmer SM, Lacouture ME. Adverse cuatneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib. Dermatol Ther. 2011;24:386–95. doi:10.1111/j.1529-8019.2011.01431.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.